Listing 1 - 10 of 21 | << page >> |
Sort by
|
Choose an application
Ce travail propose une procédure simple pour dépister la fragilité des patients gériatriques et « pré-gériatriques » au sein d’une patientèle de médecins généralistes conscientisés à l’importance de ce dépistage. La population gériatrique augmente. Parmi celle-ci, les patients fragiles confrontés à un « stress » sont à risque de déclin fonctionnel accéléré. Une évaluation de la fragilité existe déjà dans les services de gériatrie mais elle ne peut être adaptée à la médecine générale. Une procédure simple et facilement intégrée à une consultation de médecine générale a donc été instaurée. Cette procédure a pour intérêt de ne pas allonger le temps de consultation et ne demande aucun instrument particulier en sus du matériel disponible dans tout cabinet de médecine générale. L’analyse démontre que cette procédure a fait ses preuves au sein de la patientèle de mon maître de stage en dépistant les patients âgés fragiles. Il s’agit d’un outil intéressant à utiliser afin d’améliorer la prise en charge et les soins apportés aux personnages âgées. Cette analyse ouvre la porte à d’autres opportunités de travail afin d’affiner le dépistage et d’établir des plans de soins adaptés aux patients gériatriques fragiles.
Geriatrics --- General Practice --- Cognitive Dysfunction --- Aging --- Disease Susceptibility
Choose an application
"Brain aging has long been seen as a process of deterioration and decline. Today, this view been challenged with research showing that not all cognitive processes decline with age, that some improve over the course of adulthood, and those that improve can often compensate for those that decline. Chapters in this multidisciplinary volume examine the neural mechanisms underlying changes in the aging brain, changes in learning and memory, risk and protective factors, and the assessment and prevention of cognitive decline"--
Brain --- Cognition in old age. --- Cognitive Aging. --- Cognition. --- Cognitive Dysfunction --- Aging. --- physiology. --- prevention & control.
Choose an application
"Brain aging has long been seen as a process of deterioration and decline. Today, this view been challenged with research showing that not all cognitive processes decline with age, that some improve over the course of adulthood, and those that improve can often compensate for those that decline. Chapters in this multidisciplinary volume examine the neural mechanisms underlying changes in the aging brain, changes in learning and memory, risk and protective factors, and the assessment and prevention of cognitive decline"--Provided by publisher.
Brain --- Cognitive Aging. --- Cognition. --- Cognitive Dysfunction --- Cerveau --- physiology. --- prevention & control --- Physiologie --- Vieillissement
Choose an application
Quatrième de couverture : "Les fonctions exécutives peuvent être définies par un rôle de contrôle intervenant dans les situations non familières ou complexes nécessitant la coordination de différentes actions vers un but finalisé. Il s'agit de capacités de contrôle de haut niveau impliquant la prise de décision et l'inhibition de comportements inappropriés. Les fonctions exécutives sont fréquemment altérées après un traumatisme crânien sévère, ce qui peut se traduire par des troubles cognitifs mais aussi par des troubles du comportement qui sont fréquents et peuvent représenter la gêne essentielle. Des modèles théoriques tentent d'expliquer ces fonctions exécutives. L'évaluation, en particulier écologique, est au centre de la prise en charge. Les approches rééducatives sont aujourd'hui multiples et découlent des approches théoriques avec des protocoles de restauration ou de réorganisation."
Personnes atteintes de lésions cérébrales --- Fonctions exécutives (neuropsychologie) --- Troubles du comportement --- Troubles de la cognition --- Remédiation cognitive --- Personnes atteintes de lésions cérébrales. --- Troubles du comportement. --- Troubles de la cognition. --- Remédiation cognitive. --- Brain Injuries, Traumatic --- Cognition Disorders --- Locomotion --- Cognitive Dysfunction
Choose an application
Dementia --- Mild cognitive impairment. --- Cognition disorders --- Cognitive disorders --- Psychology, Pathological --- Cognitive impairment, Mild --- Impairment, Mild cognitive --- MCI (Mild cognitive impairment) --- Treatment. --- Diagnosis. --- Cognitive Dysfunction. --- Aging. --- diagnosis. --- therapy. --- Aging --- diagnosis --- therapy
Choose an application
This book provides up-to-date research on the clinical assessment and management of individuals with dementia and those with mild cognitive impairment (MCI), the fastest growing clinical population. A summary of important points at the end of chapters highlights essential clinical information and guides student learning. An all-new Clinical Guide comprises the second half of the book providing an extensive discussion of the process of assessment and evidence-based treatments for individuals in all stages of dementia.
Cognition disorders. --- Communicative disorders. --- Dementia. --- Aphrenia --- Aphronesia --- Athymia --- Dementias --- Brain --- Neurobehavioral disorders --- Psychoses --- Communication disorders (Medicine) --- Disorders of communication --- Nervous system --- Cognitive disorders --- Psychology, Pathological --- Diseases --- Cognition disorders --- Communicative disorders --- Dementia --- Cognitive Dysfunction --- Communication Disorders --- diagnosis --- etiology --- complications --- therapy
Choose an application
In America today, there are 46 million people over the age of 65 and there will be over 98 million by 2060. With aging, there are many neurological diseases that can adversely affect the brain, such as Alzheimer's disease, Lewy body dementia, and Parkinson's disease. These diseases are common and a major cause of disability and suffering. Although, in a small percentage of patients, these diseases can be related to a genetic defect, for the most part we do not fully understand their causes. Perhaps that is why they are called "degenerative diseases." Several decades ago, the diagnosis of Alzheimer's disease was made only in those who were below the age of 65 and had signs of progressive dementia. If a person had cognitive deterioration and was above the age of 65, their disorder was called "senile dementia." One of the reasons this term was used is that many clinicians thought memory loss and cognitive decline were part of normal aging. Fortunately, we have learned that disorders such as Alzheimer's disease are associated with specific pathological changes in the brain, such as neurofibrillary tangles, and that normal aging does not cause this disease. Although the origins of these degenerative brain diseases are still unclear, much progress has been made in understanding their pathophysiology and paving the way for preventative, ameliorative, and curative treatments.
Brain --- Cognitive Aging. --- Cognitive Dysfunction. --- Neurodegenerative Diseases. --- Cerveau --- Cognition --- Troubles de la cognition. --- Maladies neurodégénératives. --- Physiology. --- physiology. --- Physiologie --- Chez la personne âgée --- Aspect physiologique.
Choose an application
1. 1. The classic animal models for human psychiatric conditions involves rodents As prey species, their normal behaviors of avoidance would be considered pathological in humans and dogs. Hence, such models may not be homologous for similar behaviors found in psychiatric pathology in humans. 2. 2. Dogs exhibit pathological behavioral conditions that may be equivalent to certain human psychiatric conditions. These canine conditions appear spontaneously or endogenously in the absence of genetic or neurochemcial manipulation, and as such, may be homologous to the human condition. 3. 3. If canine conditions approach homology with human conditions they should have excellent face, predictive, and construct validity. 4. 4. The canine conditions of separation anxiety, obsessive-compulsive disorder, cognitive dysfunction, dominance aggression, and panic disorder have good to excellent validity at all explored levels for human generalized anxiety disorder, obsessive-compulsive disorder, Alzheimer's disease, impulse control disorders, and panic disorder. 5. 5. Natural canine models can aid our understanding of human psychiatric conditions.
Absence. --- Aggression. --- Animal model. --- Animal-model. --- Animal-models. --- Animal. --- Anxiety. --- Assessment. --- Avoidance. --- Behavior. --- Canine model. --- Cognition. --- Cognitive disfunction dog model. --- Cognitive dysfunction. --- Control. --- Disease. --- Disorder. --- Dog. --- Dogs. --- Dominance aggression. --- Dominance. --- Generalized anxiety disorder. --- Genetic. --- Human. --- Humans. --- Impulse control disorder. --- Level. --- Model. --- Models. --- Natural. --- Obsessive-compulsive disorder. --- Obsessive-compulsive. --- Panic disorders. --- Panic. --- Post-traumatic stress syndrome. --- Prey. --- Rodent. --- Rodents. --- Schizophrenia. --- Separation anxiety. --- Separation.
Choose an application
A number of studies have demonstrated that both morphological and biochemical indices in the brain undergo alterations in response to environmental influences. In previous work we have shown that rats raised in an enriched environmental condition (EC) perform better on a spatial memory task than rats raised in isolated conditions (IC), We have also found that EC rats have a higher density of immunoreactivity than IC rats for both low and high affinity nerve growth factor (NGF) receptors in the basal forebrain. In order to determine if these alterations were coupled with altered levels of neurotrophins in other brain regions as well, we measured neurotrophin levels in rats that were raised in EC or IC conditions. Rats were placed in the different environments at 2 months of age and 12 months later brain regions were dissected and analyzed for NGF, brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) levels using Promega ELISA kits. We found that NGF and BDNF levels were increased in the cerebral cortex, hippocampal formation, basal forebrain, and hindbrain in EC animals compared to age-matched IC animals. NT-3 was found to be increased in the basal forebrain and cerebral cortex of EC animals as well. These findings demonstrate significant alterations in NGF, BDNF, and NT-3 protein levels in several brain regions as a result of an enriched versus an isolated environment and thus provide a possible biochemical basis for behavioral and morphological alterations that have been found to occur with a shifting environmental stimulus. (C) 2000 Academic Press
Affinity ngf receptors. --- Age. --- Aged rats. --- Alzheimers-disease. --- Animal. --- Animals. --- Biochemical. --- Brain. --- Cerebral-cortex. --- Cholinergic neuron atrophy. --- Cognitive dysfunction. --- Cortex. --- Density. --- Elisa. --- Enriched. --- Enrichment. --- Environment. --- Environmental enrichment. --- Environments. --- Factor messenger-rna. --- Growth. --- Hippocampal slices. --- Hippocampal-formation. --- Hippocampal. --- Immunoreactivity. --- Increase. --- Increases. --- Learning deficits. --- Level. --- Long-term. --- Memory. --- Nerve growth-factor. --- Neurotrophic factor. --- Neurotrophin,ngf,bdnf,nt-3,elisa,enriched environment. --- Ngf. --- Protein. --- Rat-brain. --- Rat. --- Rats. --- Receptor. --- Receptors. --- Response. --- Spatial memory. --- Spatial. --- Stimulus. --- Task. --- Visual-cortex. --- Work.
Choose an application
This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future. The original research work and review articles published here highlight some unique mechanisms underlying the most prevalent pathophysiological conditions affecting human health. Other areas covered in the book include emerging treatment options and correct diagnoses using different biochemical and imaging techniques.
Medicine --- Alzheimer’s disease --- amyloid beta --- hippocampus --- Kir channels --- K+ channels --- glioblastoma multiforme --- low-grade glioma --- astrocytoma --- recurrence --- multifocal growth --- mRNA expression --- MPS1 --- TTK --- therapy --- EDTA chelation therapy --- neurodegenerative diseases --- metal detoxification --- reactive oxygen species (ROS) --- neuroinflammation --- neurodegeneration --- cognitive dysfunction --- neurofibrillary tangles --- diagnosis methods --- biomarkers --- perinatal stress --- NURR1 --- inflammation --- late-onset diseases --- early life --- artificial neural network --- deep learning --- Parkinson’s disease --- atypical parkinsonian syndrome --- dopamine transporter SPECT --- β-Amyloid --- calpain --- Collapsin Response Mediator Protein-2 --- human-neuroblastoma SH-SY5Y cells --- Somatostatin-14 --- somatostatin receptor --- brain injury --- quinpirole --- dopamine D2 receptors --- glial cell --- autophagy --- mitophagy --- multiple sclerosis --- biomarker --- neurons --- astrocytes --- Alzheimer’s and Parkinson’s diseases --- fluid and imaging biomarkers --- amyloid-β and tau --- miRNA --- extracellular vesicles --- exosomes and ectosomes --- PET --- radiotracers --- radiolabeled molecules --- n/a --- Alzheimer's disease --- Parkinson's disease --- Alzheimer's and Parkinson's diseases
Listing 1 - 10 of 21 | << page >> |
Sort by
|